Extract from the above information

This product is a new type of fluoroquinolone antibacterial drug, which achieves antibacterial effect by inhibiting the activity of bacterial DNA helicase and topoisomerase IV, hindering bacterial DNA replication. It is effective against aerobic bacteria, general anaerobic bacteria, anaerobic Gram-positive bacteria, and Gram-negative bacteria, has a killing effect on Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, and has strong antibacterial activity against a variety of drug-resistant strains.

Gatifloxacin is a racemic compound of 8-methoxyfluoroquinolone, which has a broad spectrum of activity against Gram-negative and Gram-positive microorganisms in vitro, and its R- and S-enantiomers have the same antibacterial activity. The antibacterial effect of this product is to inhibit the replication, transcription and repair process of bacterial DNA by inhibiting bacterial DNA gyrase and topoisomerase IV. The results of antibacterial experiments show that this product has antibacterial activity against most strains of the following microorganisms: 1. Gram-positive bacteria: Staphylococcus aureus (limited to strains sensitive to methicillin), coagulase-negative Staphylococci, Streptococcus pneumoniae and other Streptococcus strains. 2. Gram-negative bacteria: Haemophilus (influenza and parainfluenza), Moraxella catarrhalis, Neisseria, Acinetobacter, Klebsiella pneumoniae, Enterobacter cloacae, Proteus (Proteus mirabilis and Proteus vulgaris), Pseudomonas aeruginosa, Citrobacter and Escherichia coli. 3. Other microorganisms: Chlamydia pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae.

Through the nitro group in its molecule, it is reduced to amino group in an anaerobic environment or through the formation of free radicals, which interact with cell components and cause the death of microorganisms.

This product is a nitroimidazole derivative. Its mechanism of antimicrobial effect may be through the nitro group in its molecule, which is reduced to amino group in an anaerobic environment or through the formation of free radicals, which interact with cell components and lead to the death of microorganisms.

This product is a nitroimidazole derivative. Its mechanism of antimicrobial effect may be through the nitro group in its molecule, which is reduced to amino group in an anaerobic environment or through the formation of free radicals, which interact with cell components and lead to the death of microorganisms.

This product is a nitroimidazole derivative. Its mechanism of antimicrobial effect may be through the nitro group in its molecule, which is reduced to amino group in an anaerobic environment or through the formation of free radicals, which interact with cell components and lead to the death of microorganisms.

Through the nitro group in its molecule, it is reduced to amino group in an anaerobic environment or through the formation of free radicals, which interact with cell components and cause the death of microorganisms.